HAYLEY GRIFFIN: Open Payments
NPI 1699227538 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$885 in 25 payments from 12 companies in 2025. Trend: 2023 $629 · 2024 $561 · 2025 $885
Food & beverage: $885
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $410 |
| Galderma Laboratories, L.P. | 3 | $117 |
| LEO Pharma Inc. | 4 | $80 |
| Lilly USA, LLC | 2 | $62 |
| MERZ NORTH AMERICA, INC. | 1 | $46 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| UCB, Inc. | 1 | $28 |
| Organon LLC | 1 | $27 |
| Globus Medical, Inc. | 1 | $26 |
| MIMEDX Group, Inc. | 1 | $21 |
Products named: BOTOX, TALTZ, NEMLUVIO, ADBRY, DUPIXENT, ANZUPGO, Bimzelx, SKYRIZI.
Industry payments across HI — which companies pay providers there.
